Oslo, Norway—Antidepressants used during pregnancy do not appear to have any long-term neurodevelopmental or behavioral effects on the unborn child, according to three studies published recently in BJOG: An International Journal of Obstetrics and Gynaecology. The researchers cautioned, however, that selective serotonin reuptake inhibitors (SSRIs) used to treat depression might be associated with an increased risk of postpartum hemorrhage. The research examined the effect of SSRI use on the health of the mother and the long-term development of the child. One of the studies, from the Norwegian Institute of Public Health, focused on the results of prenatal exposure to SSRIs on motor skill development at 3 years old in 51,404 Norwegian children. Other studies were led by researchers from the University of Adelaide in Australia.